As demand for medical cannabis continues to rise, increasing numbers of countries are legalising it. There is no harmonised regulatory framework for the medical cannabis trade at the EU level but the top importing and exporting European countries are developing their own legislation.
This report analyses the legal frameworks for the following countries: Austria, Denmark, Finland, Germany, Italy, Netherlands, Portugal, Spain and the UK. They were chosen because they were among the top ten European countries for cannabis importing/exporting from 2018 to 2020, according to export and import data from the International Narcotics Control Board (INCB) for cannabis for medical and scientific purposes.
Reasons to buy
If you’re involved in the import or export of medical cannabis within Europe this report provides a comprehensive overview of your legal obligations in the key markets. Our analysts detail the obligations for businesses trading in each country at an international, EU and local level. In addition to covering international treaties that impact trade in this area, the legal frameworks for each key country are profiled, along with any relevant EU legislation. Find out which information must be provided to import or export to each country, which documents must be submitted and which licences must be obtained at what cost. Links to the text of relevant legislation are provided.
Table of contents
- Executive summary
- International law application
- EU countries – EU law application
- United Kingdom
The research is original and impartial and conducted by CannIntelligence’s multilingual legal analysis team using several sources, including: online and offline resources and data, specialist legal software, interviews with key stakeholders and government officials, and via the collaboration with local lawyers and on-the-ground professionals.